As miR‐15b and its targeted genes, including Wee1 and Bcl‐2, hold great potential for the treatment of chemoresistance, this research provides strong evidence for future development of miR‐based therapeutics strategies directed at treating osteosarcoma. This evidence concerns the gene BCL2 and osteosarcoma.